Indeed, individuals with ESRD exhibit reduced responsiveness to incretin hormones, leading to elevated glucagon levels and a higher prevalence of glucose intolerance in these patients (Jorgensen et al., 2020). This evidence concerns the gene GCG and Glucose intolerance.